White Paper

Blinding Clinical Supplies Utilizing Over-Encapsulation

Source: CapsugelĀ® | Lonza Pharma & Biotech

During the preparation of clinical studies, the method for visually blinding the dosage form is a decision that needs to be made early on in the process. While there are many blinding options available today, i.e., deprinting, mill & fill, manufacture of generic drug, and over-encapsulation to name a few, the over-encapsulation method still seems to be the most popular method. Submitted by Capsugel

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma